Cancer Neoantigens as Targets for Natural and Therapeutic Anti-Tumor Responses

This content requires opt in of marketing cookies.


Description: This webinar, presented by Dr. Robert Schreiber, addresses how mouse and human cancers have been used to identify therapeutically useful tumor neoantigens; how these neoantigens can form the basis for personalized cancer vaccines; and what additional forms of therapy are needed to optimize the therapeutic effects of personalized cancer vaccines.


Remember me
Forgot your password? Reset Password
Request an Account